JP Morgan Chase
XENE icon

JP Morgan Chase’s Xenon Pharmaceuticals XENE Stock Holding History

JP Morgan Chase’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-51,500
Closed -$1.76M – 7910
2023
Q3 		$1.76M Buy
+51,500
New +$1.93M ﹤0.01% 3637

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's XENE Position: Q1 2026 in Review

JP Morgan Chase increased its Xenon Pharmaceuticals (XENE) stake by 29% in Q1 2026, buying an estimated $19.8M and bringing the position to 1,923,610 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #948.

JP Morgan Chase first reported a position in XENE in Q2 2016 and has held it in 35 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • JP Morgan Chase held 1,923,610 shares of Xenon Pharmaceuticals worth $107M as of Q1 2026.
  • JP Morgan Chase bought 429,578 Xenon Pharmaceuticals shares in Q1 2026, an estimated $19.8M.
  • Xenon Pharmaceuticals made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #948 holding.
  • JP Morgan Chase first reported a position in Xenon Pharmaceuticals in Q2 2016 and has held it in 35 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.